Article info
PDFOriginal research
Recurrence patterns after bevacizumab in platinum-sensitive, recurrent epithelial ovarian cancer
- Correspondence to Dr Hee Seung Kim, Obstetrics and Gynecology, Seoul National University, Seoul 03080, Korea (the Republic of); bboddi0311{at}gmail.com
Citation
Recurrence patterns after bevacizumab in platinum-sensitive, recurrent epithelial ovarian cancer
Publication history
- Received April 26, 2020
- Revision received August 6, 2020
- Accepted August 7, 2020
- First published October 14, 2020.
Article Versions
- Previous version (8 December 2020).
- You are currently viewing a Previous version of this article (8 December 2020).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.